Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Chronic Kidney Disease

Mineralocorticoid receptor antagonists (MRA) improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and reduce risk of heart failure (HF) hospitalization in patients with heart failure with preserved ejection fraction (HFpEF). However, the benefit and risks o...

Full description

Saved in:
Bibliographic Details
Published in:Am J Cardiol
Main Authors: Khan, Mohammad Saud, Khan, Muhammad Shahzeb, Moustafa, Abdelmoniem, Anderson, Allen S., Mehta, Rupal, Khan, Sadiya S.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977068/
https://ncbi.nlm.nih.gov/pubmed/31843235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.11.014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items